Health-care policies during the COVID-19 pandemic in Mexico: A continuous case of heterogeneous, reactive, and unequal response

Bautista-Reyes, Daniela; Werner-Sunderland, Jimena; Aragón-Gama, Alondra Coral; Duran, Jason; Medina, Katalina; Urbina-Fuentes, Manuel; Bautista‐González, Elysse

doi:10.1016/j.hpopen.2023.100100

Cited by 2 publications

(1 citation statement)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…¿Cómo han impactado las políticas públicas impulsadas por el presidente López Obrador a los sectores más vulnerables y desprotegidos en México? En materia de atención a la salud, ha sido justamente el sector de la población clasificada en pobreza y pobreza extrema el más afectado, partiendo del entendido de que por su propia condición no tiene acceso a servicios de salud pública que brindan la SSA, el IMSS o el ISSSTE (las tres principales instituciones de salud en nuestro país) y que por lo regular era atendida a través del Seguro Popular y recientemente por el INSABI, el cual resultó un abierto fracaso al carecer de reglas claras de organización y de operación (Bautista-Reyes et al, 2023).…”

Section: La Muerte Del Seguro Popular: El Nacimiento Y La Muerte Del ...unclassified

COVID-19: ¿La pandemia nos vino como anillo al dedo?

Piña López,

Tapia Grijalva,

Ruiz García

2024

RPC

View full text Add to dashboard Cite

Introducción: Los líderes populistas alrededor del mundo se han distinguido por un manejo de la pandemia de COVID-19 basado en mensajes ambiguos, verdades a medias y hasta en mentiras deliberadas. Sin duda el presidente de México, Andrés Manuel López Obrador, ha recurrido sistemáticamente a ese tipo de mensajes. Objetivo: Analizar la conducta verbal hablada o escrita del presidente López Obrador sobre la pandemia de COVID-19, aportando datos duros que evidencian que la gestión de esta ha sido cuestionable. Metodología: Se revisaron los contenidos discursivos del presidente López Obrador en su cuenta pública de Twitter y su portal web, así como los datos oficiales sobre: 1) Los casos confirmados de la enfermedad; 2) Las defunciones acaecidas; 3) El exceso de mortalidad; 4) Los niveles de pobreza, y 5) El problema del acceso a los servicios de salud en México. Resultados: Más de 7 millones de casos confirmados de la enfermedad, 334,000 defunciones, entre 606 y 801,000 defunciones ocurridas en exceso, casi medio millón de personas que pasaron a la pobreza extrema y 30.3 millones que entre 2018 y 2022 carecieron de acceso a servicios de salud oportuna y de calidad, es el legado consecuencia del manejo político de la pandemia en México. Conclusiones: El contenido de estos puntos revela que la narrativa adoptada por el presidente López Obrador contradice su declaración de que “La pandemia nos vino como anillo al dedo”.

show abstract

Section: La Muerte Del Seguro Popular: El Nacimiento Y La Muerte Del ...unclassified

COVID-19: ¿La pandemia nos vino como anillo al dedo?

Piña López,

Tapia Grijalva,

Ruiz García

2024

RPC

View full text Add to dashboard Cite

show abstract

Regional moderate hyperthermia for mild-to-moderate COVID-19 (TherMoCoV study): a randomized controlled trial

Mancilla-Galindo,

Kammar-García,

Mendoza-Gertrudis

et al. 2023

Front. Med.

View full text Add to dashboard Cite

BackgroundTo prevent COVID-19 progression, low-cost alternatives that are available to all patients are needed. Diverse forms of thermotherapy have been proposed to prevent progression to severe/critical COVID-19.ObjectiveThe aim of this study is to evaluate the efficacy and safety of local thermotherapy to prevent disease progression in hospitalized adult patients with mild-to-moderate COVID-19.MethodsA multicenter, open-label, parallel-group, randomized, adaptive trial is used to evaluate the efficacy and safety of local thermotherapy to prevent disease progression in hospitalized adult patients with mild-to-moderate COVID-19. Eligible hospitalized adult patients with symptoms of COVID-19 with ≤5 days from symptom onset, meeting criteria for mild or moderate COVID-19, were randomly assigned to the intervention consisting of local thermotherapy via an electric heat pad in the thorax (target temperature range 39.5–42°C) continuously for 90 min, twice daily, for 5 days, or standard care. The main outcome was the proportion of patients who progressed to severe-to-critical COVID-19 or death. Patients were randomized in a 1:1 ratio through a centralized computer-generated sequence of minimization with a random component of 20%. Participants and medical staff were not blinded to the intervention.ResultsOne-hundred and five participants (thermotherapy n = 54, control n = 51) with a median age of 53 (IQR: 41–64) years were included for analysis after the early cessation of recruitment due to the closure of all temporal COVID-19 units (target sample size = 274). The primary outcome of disease progression occurred in 31.4% (16/51) of patients in the control group vs. 25.9% (14/54) of those receiving thermotherapy (risk difference = 5.5%; 95%CI: −11.8–22.7, p = 0.54). Thermotherapy was well tolerated with a median total duration of thermotherapy of 900 (IQR: 877.5–900) min. Seven (13.7%) patients in the control group and seven (12.9%) in the thermotherapy group had at least one AE (p = 0.9), none of which were causally attributed to the intervention. No statistically significant differences in serum cytokines (IL-1β, IL-6, IL-8, IL-10, IL-17, and IFN-γ) were observed between day 5 and baseline among groups.ConclusionLocal thermotherapy was safe and well-tolerated. A non-statistically significant lower proportion of patients who experienced disease progression was found in the thermotherapy group compared to standard care. Local thermotherapy could be further studied as a strategy to prevent disease progression in ambulatory settings.Clinical Trial registration: www.clinicaltrials.gov, identifier: NCT04363541.

show abstract

Health-care policies during the COVID-19 pandemic in Mexico: A continuous case of heterogeneous, reactive, and unequal response

Cited by 2 publications

References 6 publications

COVID-19: ¿La pandemia nos vino como anillo al dedo?

COVID-19: ¿La pandemia nos vino como anillo al dedo?

Regional moderate hyperthermia for mild-to-moderate COVID-19 (TherMoCoV study): a randomized controlled trial

Contact Info

Product

Resources

About